athenahealth, Inc (ATHN) Given Average Rating of “Hold” by Brokerages

Shares of athenahealth, Inc (NASDAQ:ATHN) have been given an average rating of “Hold” by the twenty-seven research firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, sixteen have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $142.85.

ATHN has been the topic of a number of analyst reports. KeyCorp reaffirmed a “buy” rating and set a $152.00 target price on shares of athenahealth in a research report on Friday, January 12th. Wells Fargo & Co dropped their target price on athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a research report on Monday, October 23rd. ValuEngine lowered athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Oppenheimer reissued a “buy” rating and issued a $184.00 price objective on shares of athenahealth in a report on Friday, October 20th. Finally, BidaskClub lowered athenahealth from a “hold” rating to a “sell” rating in a report on Tuesday, January 16th.

Shares of athenahealth (ATHN) traded up $3.80 during midday trading on Friday, hitting $131.07. The stock had a trading volume of 571,880 shares, compared to its average volume of 564,213. athenahealth has a twelve month low of $95.01 and a twelve month high of $158.66. The stock has a market capitalization of $5,250.00, a price-to-earnings ratio of 100.82, a price-to-earnings-growth ratio of 2.41 and a beta of 1.35. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.48. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The business had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. During the same period in the previous year, the company earned $0.62 earnings per share. The company’s revenue for the quarter was up 14.2% compared to the same quarter last year. research analysts expect that athenahealth will post 2.29 EPS for the current fiscal year.

In other athenahealth news, CEO Jonathan Bush sold 5,000 shares of athenahealth stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $122.69, for a total value of $613,450.00. Following the completion of the transaction, the chief executive officer now directly owns 320,807 shares in the company, valued at $39,359,810.83. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amy Abernethy sold 500 shares of athenahealth stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $134.18, for a total value of $67,090.00. Following the completion of the transaction, the director now owns 4,045 shares of the company’s stock, valued at $542,758.10. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 98,703 shares of company stock valued at $13,487,150. 3.20% of the stock is currently owned by insiders.

A number of hedge funds have recently modified their holdings of ATHN. Jackson Square Partners LLC boosted its stake in athenahealth by 55.4% in the third quarter. Jackson Square Partners LLC now owns 525,738 shares of the health services provider’s stock valued at $65,380,000 after acquiring an additional 187,491 shares during the period. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of athenahealth by 124.4% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 276,700 shares of the health services provider’s stock worth $34,410,000 after buying an additional 153,400 shares during the period. Sumitomo Mitsui Asset Management Company LTD boosted its position in shares of athenahealth by 40.3% during the fourth quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock worth $60,421,000 after buying an additional 130,545 shares during the period. Toronto Dominion Bank acquired a new position in shares of athenahealth during the second quarter worth approximately $16,863,000. Finally, First Trust Advisors LP boosted its position in shares of athenahealth by 7,309.7% during the third quarter. First Trust Advisors LP now owns 115,592 shares of the health services provider’s stock worth $14,375,000 after buying an additional 114,032 shares during the period.

COPYRIGHT VIOLATION WARNING: “athenahealth, Inc (ATHN) Given Average Rating of “Hold” by Brokerages” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/02/10/athenahealth-inc-athn-given-average-rating-of-hold-by-brokerages.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply